Molecular Formula | C20H25ClN6O3 |
Molar Mass | 432.9 |
Density | 1.43±0.1 g/cm3(Predicted) |
Melting Point | 58.5 °C |
Boling Point | 660.6±65.0 °C(Predicted) |
Solubility | DMSO: 37mg/mL, soluble |
Appearance | solid |
pKa | 2.81±0.25(Predicted) |
Storage Condition | Keep in dark place,Sealed in dry,Store in freezer, under -20°C |
WGK Germany | 3 |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.31 ml | 11.55 ml | 23.1 ml |
5 mM | 0.462 ml | 2.31 ml | 4.62 ml |
10 mM | 0.231 ml | 1.155 ml | 2.31 ml |
5 mM | 0.046 ml | 0.231 ml | 0.462 ml |
biological activity | Purvalanol B (NG-95) is an effective and selective inhibitor of cyclin-dependent kinase (CDK), and its IC50 values for cdc2-cyclin B, CDK2-cyclin A, CDK2-cyclin E and CDK5-p35 are 6 nM, 6 nM, 9 nM and 6 nM respectively. |
target | TargetValue cdc2-cyclin B (Cell-Free Assay) 6 nM CDK2-Cyclin A (Cell-Free Assay) 6 nM CDK5-P35 (Cell-Free Assay) 6 nM CDK2-Cyclin E (Cell-Free Assay) 9 nM |
Target | Value |
cdc2-cyclin B (Cell-free assay) | 6 nM |
CDK2-Cyclin A (Cell-free assay) | 6 nM |
CDK5-P35 (Cell-free assay) | 6 nM |
CDK2-Cyclin E (Cell-free assay) | 9 nM |